CFTR and hereditary disease: In the UK, approximately 10 500 people have cystic fibrosis (CF), one of the most common life-threatening genetic diseases.1 In recent years, precision medicines called CF transmembrane conductance regulator (CFTR) modulators have been developed to treat people with CF (pwCF).